person · Reporting owner

MERESMAN STANLEY J

Disclosed activity across 7 companies

Tapewire entity: 12065
SEC CIK: 0001283102

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Cloudflare, Inc.NET · Entity 2910	Director	May 11, 2022	May 12, 2022
DoorDash, Inc.DASH · Entity 1541	Director	May 24, 2023	May 26, 2023
Guardant Health, Inc.GH · Entity 3238	Director	June 15, 2022	June 17, 2022
Palo Alto Networks IncPANW · Entity 1811	Director	December 04, 2018	December 06, 2018
Snap IncSNAP · Entity 3584	Director	July 20, 2022	July 22, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cloudflare, Inc.

Report date May 11, 2022 · Filed May 12, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	2,441	Ending reported balance After 2022-05-11 transaction · row 6 6 source rows · reconciled sequence Row 1 · 2022-05-11 · Conversion · Acquired 11,000 · Balance 13,441 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Row 2 · 2022-05-11 · Sale · Disposed 5,000 · Balance 8,441 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.08 to $55.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. Row 3 · 2022-05-11 · Sale · Disposed 3,225 · Balance 5,216 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.08 to $57.06, inclusive. Row 4 · 2022-05-11 · Sale · Disposed 1,000 · Balance 4,216 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.10 to $57.98, inclusive. Row 5 · 2022-05-11 · Sale · Disposed 1,200 · Balance 3,016 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.21 to $58.93, inclusive. Row 6 · 2022-05-11 · Sale · Disposed 575 · Balance 2,441 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $59.98, inclusive.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.56 · Expires 2028-12-12	Direct	33,000	Reported balance After 2022-05-11 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-05-11 · Exercise / conversion · Disposed 11,000 · Balance 33,000 F8: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018. F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.
Class B Common StockSEC Table II · derivative / convertible security	Direct	11,000	Reported balance After 2022-05-11 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-05-11 · Exercise / conversion · Acquired 11,000 · Balance 11,000 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.
Class B Common StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-05-11 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-05-11 · Conversion · Disposed 11,000 · Balance 0 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.08 to $55.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.08 to $57.06, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.10 to $57.98, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.21 to $58.93, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $59.98, inclusive.

F8: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018.

DoorDash, Inc.

Report date May 24, 2023 · Filed May 26, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	3,557	Reported balance After 2023-05-24 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2023-05-24 · Sale · Disposed 3,846 · Balance 3,557 F1: The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2022. F2: These securities are represented by restricted stock units.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	1,100	Reported balance Holding disclosure · report date 2023-05-24 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 1,100 F3: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees.

Filing footnotes · ownership attribution and instrument terms

F1: The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2022.

F2: These securities are represented by restricted stock units.

F3: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees.

Guardant Health, Inc.

Report date June 15, 2022 · Filed June 17, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
COMMON STOCKSEC Table I · non-derivative	Direct	5,873	Reported balance After 2022-06-15 transaction · row 1 1 source row Row 1 · 2022-06-15 · Exercise / conversion · Acquired 1,814 · Balance 5,873
RESTRICTED STOCK UNITSSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-06-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-06-15 · Exercise / conversion · Disposed 1,814 · Balance 0 F1: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022. F2: Not applicable for Restricted Stock Units.

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022.

F2: Not applicable for Restricted Stock Units.

Palo Alto Networks Inc

Report date December 04, 2018 · Filed December 06, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2018-12-04 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2018-12-04 · Sale · Disposed 300 · Balance 1,658 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: This sale price represents the weighted average sale price of the shares sold ranging from $175.45 to $176.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 2 · 2018-12-04 · Sale · Disposed 858 · Balance 800 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3: This sale price represents the weighted average sale price of the shares sold ranging from $176.63 to $177.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 3 · 2018-12-04 · Sale · Disposed 600 · Balance 200 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4: This sale price represents the weighted average sale price of the shares sold ranging from $177.97 to $178.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 4 · 2018-12-04 · Sale · Disposed 200 · Balance 0 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5: This sale price represents the weighted average sale price of the shares sold ranging from $179.22 to $179.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This sale price represents the weighted average sale price of the shares sold ranging from $175.45 to $176.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3: This sale price represents the weighted average sale price of the shares sold ranging from $176.63 to $177.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F4: This sale price represents the weighted average sale price of the shares sold ranging from $177.97 to $178.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F5: This sale price represents the weighted average sale price of the shares sold ranging from $179.22 to $179.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Snap Inc

Report date July 20, 2022 · Filed July 22, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	36,059	Reported balance After 2022-07-20 transaction · row 1 1 source row Row 1 · 2022-07-20 · Grant · Acquired 9,114 · Balance 36,059 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from July 20, 2022. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.03 · Expires 2032-07-19	Direct	65,553	Reported balance After 2022-07-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-07-20 · Grant · Acquired 14,864 · Balance 65,553 F2: 100% of the shares subject to the option will vest upon the reporting person's completion of one year of continuous service from July 20, 2022. The shares subject to the option will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the shares subject to the option will be deemed fully vested immediately.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from July 20, 2022. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately.

F2: 100% of the shares subject to the option will vest upon the reporting person's completion of one year of continuous service from July 20, 2022. The shares subject to the option will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the shares subject to the option will be deemed fully vested immediately.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

LINKEDIN CORP

Report date December 08, 2016 · Filed December 09, 2016

Section 16 reporting ended · disclosed 2016-12-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	Reported balance After 2016-12-08 transaction · row 1 1 source row Row 1 · 2016-12-08 · Disposition to issuer · Disposed 1,550 · Balance 0 F1: The shares of Class A Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration"). The reported number represents restricted stock units granted on June 9, 2016 which were accelerated pursuant to the terms of Issuer's 2011 Equity Incentive Plan. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	Reported balance After 2016-12-08 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2016-12-08 · Disposition to issuer · Disposed 3,374 · Balance 0 F3: The shares of Class A Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee Footnote	Reported balance After 2016-12-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-12-08 · Disposition to issuer · Disposed 3,032 · Balance 0 F5: The shares of Class B Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration and had no expiration date. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $172.02 · Expires 2023-06-13	Direct	Reported balance After 2016-12-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-12-08 · Disposition to issuer · Disposed 2,433 · Balance 0 F6: The stock option was granted on June 13, 2013 for 2,433 shares. 2,433 vested shares subject to the stock option were cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the stock option, multiplied by (y) the number of disposed option shares.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $202.50 · Expires 2024-08-04	Direct	Reported balance After 2016-12-08 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2016-12-08 · Disposition to issuer · Disposed 1,560 · Balance 0 F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $197.10 · Expires 2025-08-03	Direct	Reported balance After 2016-12-08 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2016-12-08 · Disposition to issuer · Disposed 1,197 · Balance 0 F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of Class A Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration"). The reported number represents restricted stock units granted on June 9, 2016 which were accelerated pursuant to the terms of Issuer's 2011 Equity Incentive Plan.

F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration.

F3: The shares of Class A Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration.

F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees.

F5: The shares of Class B Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration and had no expiration date.

F6: The stock option was granted on June 13, 2013 for 2,433 shares. 2,433 vested shares subject to the stock option were cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the stock option, multiplied by (y) the number of disposed option shares.

F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration.

Medallia, Inc.

Report date October 29, 2021 · Filed November 02, 2021

Section 16 reporting ended · disclosed 2021-11-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2021-10-29 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2021-10-29 · Disposition to issuer · Disposed 22,782 · Balance 7,791 F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Project Metal Parent, LLC and Project Metal Merger Sub, Inc. dated July 25, 2021, each share of issued and outstanding Issuer common stock was cancelled and converted into the right to receive $34.00 in cash. Row 2 · 2021-10-29 · Disposition to issuer · Disposed 7,791 · Balance 0 F2: The shares are represented by restricted stock units, or RSUs. Pursuant to the terms of the Issuer's 2019 Equity Incentive Plan and the Outside Director Compensation Plan, the RSUs vested in full in connection with a change in control. F3: Immediately prior to the effective time of the merger, each vested RSU was cancelled and converted into a right to receive $34.00 in cash for each outstanding unit.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Project Metal Parent, LLC and Project Metal Merger Sub, Inc. dated July 25, 2021, each share of issued and outstanding Issuer common stock was cancelled and converted into the right to receive $34.00 in cash.

F2: The shares are represented by restricted stock units, or RSUs. Pursuant to the terms of the Issuer's 2019 Equity Incentive Plan and the Outside Director Compensation Plan, the RSUs vested in full in connection with a change in control.

F3: Immediately prior to the effective time of the merger, each vested RSU was cancelled and converted into a right to receive $34.00 in cash for each outstanding unit.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 16, 2020 Filed Dec 17, 2020 16:49 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	15,000	$33.88	$508,272.00	Disclosure SEC source: 0001246360-20-001965 · form.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Meresman Family Trust Disclosed balance after: 80,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.78 to $34.09, inclusive. F5 · ownership.nature: The shares are held of record by the Meresman Family Trust U/D/T dated 9/13/89 for which the reporting person serves as a trustee. Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:49 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	7,500	$34.38	$257,869.50	Disclosure SEC source: 0001246360-20-001965 · form.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 87,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), and (6) to this Form 4. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
December 11, 2020 Filed Dec 16, 2020 02:03 UTC	DoorDash, Inc. DASH · Entity 1541	OtherClass A Common Stock	144,450	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-033992 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,450 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. F2 · balance_after: The shares are represented by restricted stock units. Read SEC document
December 11, 2020 Filed Dec 16, 2020 02:03 UTC	DoorDash, Inc. DASH · Entity 1541	OtherCommon Stock	144,450	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-033992 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. Read SEC document
December 10, 2020 Filed Dec 14, 2020 16:52 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	4,954	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001576280-20-000003 · wf-form4_160798270718277.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,879 Underlying: COMMON STOCK · 4,954 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
December 10, 2020 Filed Dec 14, 2020 16:52 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	4,954	$125.44	$621,429.76	Disclosure SEC source: 0001576280-20-000003 · wf-form4_160798270718277.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
December 10, 2020 Filed Dec 14, 2020 16:52 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	4,954	$5.94	$29,426.76	Disclosure SEC source: 0001576280-20-000003 · wf-form4_160798270718277.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 08, 2020 Filed Dec 11, 2020 02:21 UTC	DoorDash, Inc. DASH · Entity 1541	GrantCommon Stock	144,450	$0.00	$0.00	Disclosure SEC source: 0000899243-20-033410 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,450 F1 · security: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. F2 · shares: The reported shares are represented by restricted stock units, or RSUs, of which 72,225 have vested and the remaining 72,225 shares vest in 24 equal monthly installments beginning on January 1, 2021.Settlement of vested shares will not occur for a period of at least 180 days following the effectiveness of the Issuer's registration statement in connection with its initial public offering of Class A Common Stock. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	ConversionClass B Common Stock · Derivative	24,000	$0.00	$0.00	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · derivative · entry 6 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.underlying: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	Exercise / conversionClass B Common Stock · Derivative	24,000	$0.00	$0.00	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · derivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.underlying: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	Exercise / conversionStock Option (right to buy) · Derivative	24,000	$0.00 Strike: $8.56	$0.00	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · derivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,000 Underlying: Class B Common Stock · 24,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018. F1 · derivative.underlying: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	SaleClass A Common Stock	12,800	$64.61	$827,002.88	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,622 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $64.95, inclusive. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	SaleClass A Common Stock	11,200	$64.07	$717,552.64	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,422 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.51 to $64.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document
November 17, 2020 Filed Nov 18, 2020 16:42 UTC	Cloudflare, Inc. NET · Entity 2910	ConversionClass A Common Stock	24,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-031445 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document
November 10, 2020 Filed Nov 12, 2020 17:07 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	5,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-016339 · wf-form4_160521873593371.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,833 Underlying: COMMON STOCK · 5,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
November 10, 2020 Filed Nov 12, 2020 17:07 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	5,000	$110.30	$551,500.00	Disclosure SEC source: 0001628280-20-016339 · wf-form4_160521873593371.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
November 10, 2020 Filed Nov 12, 2020 17:07 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	5,000	$5.94	$29,700.00	Disclosure SEC source: 0001628280-20-016339 · wf-form4_160521873593371.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 12, 2020 Filed Oct 14, 2020 16:48 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	5,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-014476 · wf-form4_160270849641841.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,833 Underlying: COMMON STOCK · 5,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
October 12, 2020 Filed Oct 14, 2020 16:48 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	5,000	$109.37	$546,850.00	Disclosure SEC source: 0001628280-20-014476 · wf-form4_160270849641841.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
October 12, 2020 Filed Oct 14, 2020 16:48 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	5,000	$5.94	$29,700.00	Disclosure SEC source: 0001628280-20-014476 · wf-form4_160270849641841.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 17, 2020 Filed Sep 17, 2020 19:07 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	7,500	$26.91	$201,813.75	Disclosure SEC source: 0001246360-20-001531 · form.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 95,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.60 to $27.00, inclusive. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
September 16, 2020 Filed Sep 17, 2020 19:07 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	15,000	$28.78	$431,662.50	Disclosure SEC source: 0001246360-20-001531 · form.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Meresman Family Trust Disclosed balance after: 95,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.4350 to $28.99, inclusive. F5 · ownership.nature: The shares are held of record by the Meresman Family Trust U/D/T dated 9/13/89 for which the reporting person serves as a trustee. Read SEC document
September 15, 2020 Filed Sep 17, 2020 19:07 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	7,500	$30.15	$226,095.00	Disclosure SEC source: 0001246360-20-001531 · form.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 102,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.76 to $30.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), and (6) to this Form 4. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
September 10, 2020 Filed Sep 14, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	5,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-013562 · wf-form4_160011758253472.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,833 Underlying: COMMON STOCK · 5,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
September 10, 2020 Filed Sep 14, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	5,000	$94.22	$471,100.00	Disclosure SEC source: 0001628280-20-013562 · wf-form4_160011758253472.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
September 10, 2020 Filed Sep 14, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	5,000	$5.94	$29,700.00	Disclosure SEC source: 0001628280-20-013562 · wf-form4_160011758253472.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 26, 2020 Filed Aug 28, 2020 16:21 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	25,000	$34.47	$861,767.50	Disclosure SEC source: 0001246360-20-001496 · form.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 110,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.47 to $34.49, inclusive. F5 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
August 26, 2020 Filed Aug 28, 2020 16:21 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	25,000	$34.47	$861,787.50	Disclosure SEC source: 0001246360-20-001496 · form.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Meresman Family Trust Disclosed balance after: 110,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.47 to $34.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · ownership.nature: The shares are held of record by the Meresman Family Trust U/D/T dated 9/13/89 for which the reporting person serves as a trustee. Read SEC document
August 10, 2020 Filed Aug 12, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	5,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-012536 · wf-form4_159726635484290.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,833 Underlying: COMMON STOCK · 5,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
August 10, 2020 Filed Aug 12, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	5,000	$87.00	$435,000.00	Disclosure SEC source: 0001628280-20-012536 · wf-form4_159726635484290.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
August 10, 2020 Filed Aug 12, 2020 17:06 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	5,000	$5.94	$29,700.00	Disclosure SEC source: 0001628280-20-012536 · wf-form4_159726635484290.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 30, 2020 Filed Jul 30, 2020 19:56 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	7,500	$30.13	$226,005.75	Disclosure SEC source: 0001209191-20-044102 · doc4.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 135,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.66 to $30.51, inclusive. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
July 29, 2020 Filed Jul 30, 2020 19:56 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	15,000	$30.10	$451,542.00	Disclosure SEC source: 0001209191-20-044102 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 135,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.71 to $30.36, inclusive. F5 · ownership.nature: The shares are held of record by the Meresman Family Trust U/D/T dated 9/13/89 for which the reporting person serves as a trustee. Read SEC document
July 28, 2020 Filed Jul 30, 2020 19:56 UTC	Medallia, Inc. MDLA · Entity 133980	SaleCommon Stock	7,500	$30.63	$229,720.50	Disclosure SEC source: 0001209191-20-044102 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 142,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $31.355, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (6) to this Form 4. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document
July 19, 2020 Filed Jul 22, 2020 18:42 UTC	Snap Inc SNAP · Entity 3584	GrantOption (right to buy) · Derivative	10,612	$0.00 Strike: $24.24	$0.00	Disclosure SEC source: 0001209191-20-043383 · doc4.xml · derivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,645 Underlying: Class A Common Stock · 10,612 shares Expires 2030-07-18 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest upon the reporting person's completion of one year of continuous service from July 19, 2020. The shares subject to the option will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the shares subject to the option will be deemed fully vested immediately. Read SEC document
July 19, 2020 Filed Jul 22, 2020 18:42 UTC	Snap Inc SNAP · Entity 3584	GrantClass A Common Stock	5,800	$0.00	$0.00	Disclosure SEC source: 0001209191-20-043383 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from July 19, 2020. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately. Read SEC document
July 10, 2020 Filed Jul 14, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	6,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-010323 · wf-form4_159476040619720.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,833 Underlying: COMMON STOCK · 6,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
July 10, 2020 Filed Jul 14, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	6,000	$86.66	$519,960.00	Disclosure SEC source: 0001628280-20-010323 · wf-form4_159476040619720.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
July 10, 2020 Filed Jul 14, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	6,000	$5.94	$35,640.00	Disclosure SEC source: 0001628280-20-010323 · wf-form4_159476040619720.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC	Guardant Health, Inc. GH · Entity 3238	GrantSTOCK OPTION (RIGHT TO BUY) · Derivative	4,840	$0.00 Strike: $77.09	$0.00	Disclosure SEC source: 0001628280-20-009564 · wf-form4_159234457407405.xml · derivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,840 Underlying: COMMON STOCK · 4,840 shares Expires 2030-06-11 F1 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders. Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC	Guardant Health, Inc. GH · Entity 3238	GrantCOMMON STOCK	2,757	$0.00	$0.00	Disclosure SEC source: 0001628280-20-009564 · wf-form4_159234457407405.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	6,000	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,833 Underlying: COMMON STOCK · 6,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	6,000	$80.59	$483,540.00	Disclosure SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	6,000	$5.94	$35,640.00	Disclosure SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 02, 2020 Filed Jun 3, 2020 16:54 UTC	Cloudflare, Inc. NET · Entity 2910	GrantClass A Common Stock	6,622	$0.00	$0.00	Disclosure SEC source: 0000899243-20-015107 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,622 F1 · shares: Represents an automatic annual restricted stock unit, or RSU, award issued pursuant to the Issuer's Outside Director Compensation Policy. The RSUs vest on the earlier of (i) June 2, 2021 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 29, 2020 Filed May 29, 2020 21:20 UTC	Medallia, Inc. MDLA · Entity 133980	GrantCommon Stock	6,541	$0.00	$0.00	Disclosure SEC source: 0001209191-20-033096 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,191 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) May 29, 2021 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 11, 2020 Filed May 13, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	6,500	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-007715 · wf-form4_158940363240304.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,833 Underlying: COMMON STOCK · 6,500 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document
May 11, 2020 Filed May 13, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	6,500	$86.50	$562,250.00	Disclosure SEC source: 0001628280-20-007715 · wf-form4_158940363240304.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document
May 11, 2020 Filed May 13, 2020 17:00 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	6,500	$5.94	$38,610.00	Disclosure SEC source: 0001628280-20-007715 · wf-form4_158940363240304.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 13, 2020 Filed Apr 15, 2020 17:02 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative	9,500	$0.00 Strike: $5.94	$0.00	Disclosure SEC source: 0001628280-20-005002 · wf-form4_158698455044500.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,333 Underlying: COMMON STOCK · 9,500 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.